Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 613

1.

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors.

Tamminga M, de Wit S, Hiltermann TJN, Timens W, Schuuring E, Terstappen LWMM, Groen HJM.

J Immunother Cancer. 2019 Jul 10;7(1):173. doi: 10.1186/s40425-019-0649-2.

2.

Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study.

Witlox WJA, Ramaekers BLT, Groen HJM, Dingemans AM, Praag J, Belderbos J, van der Noort V, van Tinteren H, Joore MA, De Ruysscher DKM.

Acta Oncol. 2019 Jul 1:1-4. doi: 10.1080/0284186X.2019.1629016. [Epub ahead of print] No abstract available.

PMID:
31256737
3.

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

Lindsay CR, Blackhall FH, Carmel A, Fernandez-Gutierrez F, Gazzaniga P, Groen HJM, Hiltermann TJN, Krebs MG, Loges S, López-López R, Muinelo-Romay L, Pantel K, Priest L, Riethdorf S, Rossi E, Terstappen L, Wikman H, Soria JC, Farace F, Renehan A, Dive C, Besse B, Michiels S.

Eur J Cancer. 2019 Aug;117:60-68. doi: 10.1016/j.ejca.2019.04.019. Epub 2019 Jun 27.

4.

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.

Degens JHRJ, Sanders KJC, de Jong EEC, Groen HJM, Smit EF, Aerts JG, Schols AMWJ, Dingemans AC.

Lung Cancer. 2019 Jul;133:130-135. doi: 10.1016/j.lungcan.2019.05.021. Epub 2019 May 20.

5.

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations.

Willemsen AECAB, Krausz S, Ligtenberg MJL, Grünberg K, Groen HJM, Voest EE, Cuppen EPJG, van Laarhoven HWM, van Herpen CML.

Br J Cancer. 2019 Jul;121(1):34-36. doi: 10.1038/s41416-019-0489-3. Epub 2019 May 27.

PMID:
31130724
6.

Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.

Du Y, Zhao Y, Sidorenkov G, de Bock GH, Cui X, Huang Y, Dorrius MD, Rook M, Groen HJM, Heuvelmans MA, Vliegenthart R, Chen K, Xie X, Liu S, Oudkerk M, Ye Z.

Cancer Biol Med. 2019 Feb;16(1):181-188. doi: 10.20892/j.issn.2095-3941.2018.0237.

7.

Circulating tumor cells are prognostic in SCLC, but still lack clinical application.

Tamminga M, Groen HJM.

Ann Oncol. 2019 May 16. pii: mdz162. doi: 10.1093/annonc/mdz162. [Epub ahead of print] No abstract available.

PMID:
31095269
8.

Association between parity and persistent weight gain at age 40-60 years: a longitudinal prospective cohort study.

Zoet GA, Paauw ND, Groenhof K, Franx A, Gansevoort RT, Groen H, Van Rijn B, Lely T.

BMJ Open. 2019 May 5;9(5):e024279. doi: 10.1136/bmjopen-2018-024279.

9.

Air Pollution and Adenocarcinoma in Never-Smokers.

Groen HJM, Hiltermann TJN.

J Thorac Oncol. 2019 May;14(5):761-763. doi: 10.1016/j.jtho.2019.02.007. No abstract available.

PMID:
31027739
10.

Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.

Xia C, Rook M, Pelgrim GJ, Sidorenkov G, Wisselink HJ, van Bolhuis JN, van Ooijen PMA, Guo J, Oudkerk M, Groen H, van den Berge M, van der Harst P, Dijkstra H, Vonder M, Heuvelmans MA, Dorrius MD, De Deyn PP, de Bock GH, Dotinga A, Vliegenthart R.

Eur J Epidemiol. 2019 Apr 23. doi: 10.1007/s10654-019-00519-0. [Epub ahead of print]

PMID:
31016436
11.

Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.

Zwertbroek EF, Franssen MTM, Broekhuijsen K, Langenveld J, Bremer H, Ganzevoort W, van Loon AJ, van Pampus MG, Rijnders RJP, Sikkema MJ, Scherjon SA, Woiski MD, Mol BWJ, van Baar AL, Groen H; HYPITAT-II Study Group.

Am J Obstet Gynecol. 2019 Mar 30. pii: S0002-9378(19)30526-5. doi: 10.1016/j.ajog.2019.03.024. [Epub ahead of print]

PMID:
30940558
12.

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).

Hermans BCM, Derks JL, Thunnissen E, van Suylen RJ, den Bakker MA, Groen HJM, Smit EF, Damhuis RA, van den Broek EC, Stallinga CM, Roemen GM, Speel EJM, Dingemans AC; PALGA-group.

Lung Cancer. 2019 Apr;130:179-186. doi: 10.1016/j.lungcan.2019.02.022. Epub 2019 Feb 21.

PMID:
30885341
13.

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis.

Holleman MS, van Tinteren H, Groen HJ, Al MJ, Uyl-de Groot CA.

Onco Targets Ther. 2019 Feb 20;12:1413-1421. doi: 10.2147/OTT.S189438. eCollection 2019. Review.

14.

Recurrence risk of preeclampsia in a linked population-based cohort: Effects of first pregnancy maximum diastolic blood pressure and gestational age.

Bernardes TP, Mol BW, Ravelli ACJ, van den Berg PP, Boezen HM, Groen H.

Pregnancy Hypertens. 2019 Jan;15:32-36. doi: 10.1016/j.preghy.2018.10.010. Epub 2018 Nov 2.

PMID:
30825924
15.

The effects of a pre-conception lifestyle intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep and quality of life.

van Dammen L, Wekker V, de Rooij SR, Mol BWJ, Groen H, Hoek A, Roseboom TJ.

PLoS One. 2019 Feb 25;14(2):e0212914. doi: 10.1371/journal.pone.0212914. eCollection 2019.

16.

Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.

Bernardes TP, Zwertbroek EF, Broekhuijsen K, Koopmans C, Boers K, Owens M, Thornton J, van Pampus MG, Scherjon SA, Wallace K, Langenveld J, van den Berg PP, Franssen MTM, Mol BWJ, Groen H.

Ultrasound Obstet Gynecol. 2019 Apr;53(4):443-453. doi: 10.1002/uog.20224.

17.

Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients.

de Goeje PL, Poncin M, Bezemer K, Kaijen-Lambers MEH, Groen HJM, Smit EF, Dingemans AC, Kunert A, Hendriks RW, Aerts JGJV.

Clin Cancer Res. 2019 Apr 1;25(7):2219-2227. doi: 10.1158/1078-0432.CCR-18-2243. Epub 2019 Jan 14.

PMID:
30642911
18.

Preconception lifestyle intervention reduces long term energy intake in women with obesity and infertility: a randomised controlled trial.

van Elten TM, Karsten MDA, Geelen A, Gemke RJBJ, Groen H, Hoek A, van Poppel MNM, Roseboom TJ.

Int J Behav Nutr Phys Act. 2019 Jan 8;16(1):3. doi: 10.1186/s12966-018-0761-6.

19.

Surgical experience and patient-related restrictions predict the adequacy of cervical mediastinoscopy in non-small cell lung carcinoma lymph node staging.

Klinkenberg TJ, Bouma W, Van De Wauwer C, Wolf RFE, Mariani MA, Groen HJM.

J Cardiothorac Surg. 2018 Dec 29;13(1):134. doi: 10.1186/s13019-018-0821-7.

20.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
21.

Trajectory of Cardiovascular Risk Factors After Hypertensive Disorders of Pregnancy.

Groenhof TKJ, Zoet GA, Franx A, Gansevoort RT, Bots ML, Groen H, Lely AT; PREVEND Group.

Hypertension. 2019 Jan;73(1):171-178. doi: 10.1161/HYPERTENSIONAHA.118.11726.

PMID:
30571544
22.

Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.

Heuvelmans MA, Vonder M, Rook M, Groen HJM, De Bock GH, Xie X, Ijzerman MJ, Vliegenthart R, Oudkerk M.

J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379.

PMID:
30550403
23.

Cardiometabolic Health in Relation to Lifestyle and Body Weight Changes 3⁻8 Years Earlier.

Van Elten TM, Van Poppel MNM, Gemke RJBJ, Groen H, Hoek A, Mol BW, Roseboom TJ.

Nutrients. 2018 Dec 10;10(12). pii: E1953. doi: 10.3390/nu10121953.

24.

Single tube liquid biopsy for advanced non-small cell lung cancer.

de Wit S, Rossi E, Weber S, Tamminga M, Manicone M, Swennenhuis JF, Groothuis-Oudshoorn CGM, Vidotto R, Facchinetti A, Zeune LL, Schuuring E, Zamarchi R, Hiltermann TJN, Speicher MR, Heitzer E, Terstappen LWMM, Groen HJM.

Int J Cancer. 2019 Jun 15;144(12):3127-3137. doi: 10.1002/ijc.32056. Epub 2019 Jan 28.

PMID:
30536653
25.

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer.

Cramer-van der Welle CM, Peters BJM, Schramel FMNH, Klungel OH, Groen HJM, van de Garde EMW; Santeon NSCLC Study Group; Santeon NSCLC study group.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801100. doi: 10.1183/13993003.01100-2018. Print 2018 Dec.

26.

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.

Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE.

Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26.

PMID:
30478423
27.

KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC.

Niemantsverdriet M, Schuuring E, Elst AT, van der Wekken AJ, van Kempen LC, van den Berg A, Groen HJM.

J Thorac Oncol. 2018 Dec;13(12):e249-e251. doi: 10.1016/j.jtho.2018.07.103. No abstract available.

PMID:
30467046
28.

Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous Population.

Broekhuizen H, Groothuis-Oudshoorn CGM, Vliegenthart R, Groen HJM, IJzerman MJ.

Value Health. 2018 Nov;21(11):1269-1277. doi: 10.1016/j.jval.2018.01.021.

PMID:
30442273
29.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

30.

Effects of a preconception lifestyle intervention in obese infertile women on diet and physical activity; A secondary analysis of a randomized controlled trial.

van Elten TM, Karsten MDA, Geelen A, van Oers AM, van Poppel MNM, Groen H, Gemke RJBJ, Mol BW, Mutsaerts MAQ, Roseboom TJ, Hoek A; LIFEstyle study group.

PLoS One. 2018 Nov 7;13(11):e0206888. doi: 10.1371/journal.pone.0206888. eCollection 2018.

31.

Long-term effects of a preconception lifestyle intervention on cardiometabolic health of overweight and obese women.

Wekker V, Huvinen E, van Dammen L, Rono K, Painter RC, Zwinderman AH, van de Beek C, Sarkola T, Mol BWJ, Groen H, Hoek A, Koivusalo SB, Roseboom TJ, Eriksson JG.

Eur J Public Health. 2019 Apr 1;29(2):308-314. doi: 10.1093/eurpub/cky222.

32.

A lifestyle intervention improves sexual function of women with obesity and infertility: A 5 year follow-up of a RCT.

Wekker V, Karsten MDA, Painter RC, van de Beek C, Groen H, Mol BWJ, Hoek A, Laan E, Roseboom TJ.

PLoS One. 2018 Oct 23;13(10):e0205934. doi: 10.1371/journal.pone.0205934. eCollection 2018.

33.

Reply to A. Addeo et al, H. Zeng et al, and C.G. Rusthoven.

De Ruysscher DK, Groen HJ.

J Clin Oncol. 2018 Oct 22:JCO1800863. doi: 10.1200/JCO.18.00863. [Epub ahead of print] No abstract available.

PMID:
30346900
34.

Maternal right ventricular function, uteroplacental circulation in first trimester, and pregnancy outcome in women with congenital heart disease.

Siegmund AS, Kampman MAM, Oudijk MA, Mulder BJM, Sieswerda GT, Koenen SV, Hummel YM, de Laat MWM, Sollie-Szarynska KM, Groen H, van Dijk APJ, van Veldhuisen DJ, Bilardo CM, Pieper PG.

Ultrasound Obstet Gynecol. 2018 Oct 17. doi: 10.1002/uog.20148. [Epub ahead of print]

PMID:
30334300
35.

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors.

Atrafi F, Groen HJM, Byers LA, Garralda E, Lolkema MP, Sangha RS, Viteri S, Chae YK, Camidge DR, Gabrail NY, Hu B, Tian T, Nuthalapati S, Hoening E, He L, Komarnitsky P, Calles A.

Clin Cancer Res. 2019 Jan 15;25(2):496-505. doi: 10.1158/1078-0432.CCR-18-2014. Epub 2018 Oct 16.

PMID:
30327308
36.

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis.

de Wit S, Zeune LL, Hiltermann TJN, Groen HJM, Dalum GV, Terstappen LWMM.

Cancers (Basel). 2018 Oct 10;10(10). pii: E377. doi: 10.3390/cancers10100377.

37.

Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.

de Boer HR, Pool M, Joosten E, Everts M, Samplonius DF, Helfrich W, Groen HJM, van Cooten S, Fusetti F, Fehrmann RSN, de Vries EGE, van Vugt MATM.

Oncogene. 2019 Feb;38(9):1477-1488. doi: 10.1038/s41388-018-0522-7. Epub 2018 Oct 10.

PMID:
30305724
38.

Respiratory level tracking with visual biofeedback for consistent breath-hold level with potential application in image-guided interventions.

Heerink WJ, Dorrius MD, Groen HJM, Van Ooijen PMA, Vliegenthart R, Oudkerk M.

Eur Radiol Exp. 2018 Sep 5;2:22. doi: 10.1186/s41747-018-0052-7. eCollection 2018 Dec.

39.

Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope?

De Ruysscher DK, Groen HJ.

Oncotarget. 2018 Aug 17;9(64):32274-32275. doi: 10.18632/oncotarget.25866. eCollection 2018 Aug 17. No abstract available.

40.

[An enlarged thymus associated with Graves' disease].

Wouters MPAM, Wolffenbuttel BHR, Links TP, Groen HJM, Wouters RSME.

Ned Tijdschr Geneeskd. 2018 Jul 20;162. pii: D2905. Dutch.

PMID:
30182634
41.

Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.

Yang K, Li J, Zhao J, Ren P, Wang Z, Wei B, Dong B, Sun R, Wang X, Groen HJM, Ma J, Guo Y.

Anal Chem. 2018 Oct 2;90(19):11203-11209. doi: 10.1021/acs.analchem.8b01776. Epub 2018 Sep 11.

PMID:
30156405
42.

A systematic review and meta-analysis of lifestyle interventions in women of reproductive age with overweight or obesity: the effects on symptoms of depression and anxiety.

van Dammen L, Wekker V, de Rooij SR, Groen H, Hoek A, Roseboom TJ.

Obes Rev. 2018 Dec;19(12):1679-1687. doi: 10.1111/obr.12752. Epub 2018 Aug 28.

PMID:
30155959
43.

Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study.

Ettema EM, Kuipers J, van Faassen M, Groen H, van Roon AM, Lefrandt JD, Westerhuis R, Kema IP, van Goor H, Gansevoort RT, Gaillard CAJM, Franssen CFM.

BMC Nephrol. 2018 Aug 22;19(1):214. doi: 10.1186/s12882-018-0997-z.

44.

Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?

van der Wekken AJ, Kok K, Groen HJM.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2130-S2132. doi: 10.21037/jtd.2018.06.45. No abstract available.

45.

Determinants of successful lifestyle change during a 6-month preconception lifestyle intervention in women with obesity and infertility.

Karsten MDA, van Oers AM, Groen H, Mutsaerts MAQ, van Poppel MNM, Geelen A, van de Beek C, Painter RC, Mol BWJ, Roseboom TJ, Hoek A; LIFEstyle study group.

Eur J Nutr. 2018 Aug 3. doi: 10.1007/s00394-018-1798-7. [Epub ahead of print]

PMID:
30076459
46.

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification.

Meedendorp AD, Ter Elst A, 't Hart NA, Groen HJM, Schuuring E, van der Wekken AJ.

Front Oncol. 2018 May 22;8:176. doi: 10.3389/fonc.2018.00176. eCollection 2018.

47.

Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.

De Ruysscher D, Dingemans AC, Praag J, Belderbos J, Tissing-Tan C, Herder J, Haitjema T, Ubbels F, Lagerwaard F, El Sharouni SY, Stigt JA, Smit E, van Tinteren H, van der Noort V, Groen HJM.

J Clin Oncol. 2018 Aug 10;36(23):2366-2377. doi: 10.1200/JCO.2017.77.5817. Epub 2018 May 22.

PMID:
29787357
48.

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.

Walter JE, Heuvelmans MA, Yousaf-Khan U, Dorrius MD, Thunnissen E, Schermann A, Groen HJM, van der Aalst CM, Nackaerts K, Vliegenthart R, de Koning HJ, Oudkerk M.

J Thorac Oncol. 2018 Sep;13(9):1410-1414. doi: 10.1016/j.jtho.2018.05.006. Epub 2018 Jul 12.

PMID:
29775805
49.

Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.

Walter JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, Groen HJM, Aalst CMV, Nackaerts K, Ooijen PMAV, Koning HJ, Vliegenthart R, Oudkerk M.

Thorax. 2018 Aug;73(8):741-747. doi: 10.1136/thoraxjnl-2017-211376. Epub 2018 Apr 16.

PMID:
29661918
50.

Association between periconceptional weight loss and maternal and neonatal outcomes in obese infertile women.

van Oers AM, Mutsaerts MAQ, Burggraaff JM, Kuchenbecker WKH, Perquin DAM, Koks CAM, van Golde R, Kaaijk EM, Broekmans FJ, de Bruin JP, van der Veen F, Nap AW, Gondrie ETCM, Mol BWJ, Groen H, Hoek A; LIFEstyle study group.

PLoS One. 2018 Mar 28;13(3):e0192670. doi: 10.1371/journal.pone.0192670. eCollection 2018.

Supplemental Content

Support Center